Find a Supplier
Add Company
Archive
Contact Us Subscribe to Newsletter

Archive | Bachem AG

Page 8 of 8
Bachem Switches Financial Reporting from IFRS to Swiss GAAP FER
Bachem Switches Financial Reporting from IFRS to Swiss GAAP FER

Thursday 22nd August 2013

By  Bachem AG Learn More >
Bachem and Axon Neuroscience Sign Contract for Finished Dosage Forms of Peptide-Protein Conjugate
Bachem and Axon Neuroscience Sign Contract for Finished Dosage Forms of Peptide-Protein Conjugate

Thursday 22nd August 2013

By  Bachem AG Learn More >
Bachem Add 11 New Products to Online Catalogue of Peptides, Amino Acid Derivatives, Biochemical and Immunology Products
Bachem Add 11 New Products to Online Catalogue of Peptides, Amino Acid Derivatives, Biochemical and Immunology Products

Monday 1st July 2013

By  Bachem AG Learn More >
Immunological Kits and Peptide Products Added to Online Catalogue
Immunological Kits and Peptide Products Added to Online Catalogue

Friday 29th March 2013

By  Bachem AG Learn More >
Peptide, Biochemicals and Immunology Products
Peptide, Biochemicals and Immunology Products

Tuesday 5th February 2013

By  Bachem AG Learn More >
Bachem cGMP Manufacturing Capabilities
Bachem cGMP Manufacturing Capabilities

Thursday 29th November 2012

By  Bachem AG Learn More >
Bachem Granted Manufacturing License by Japanese Ministry of Health Labour and Welfare
Bachem Granted Manufacturing License by Japanese Ministry of Health Labour and Welfare

Thursday 15th November 2012

By  Bachem AG Learn More >
Bachem AG Release Seven New Products
Bachem AG Release Seven New Products

Friday 19th October 2012

By  Bachem AG Learn More >
Bachem Well Positioned in Demanding Market
Bachem Well Positioned in Demanding Market

Thursday 6th September 2012

By  Bachem AG Learn More >
Fmoc-Tyrosine Derivative
Fmoc-Tyrosine Derivative

Friday 20th July 2012

By  Bachem AG Learn More >
Page 8 of 8